Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+259.9%
5Y CAGR+159.7%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+259.9%/yr
Annual compound
5Y CAGR
+159.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
118x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.47M | +224.6% |
| 2024 | $1.07M | +0.8% |
| 2023 | $1.06M | +1324.9% |
| 2022 | $74453.00 | +273.7% |
| 2021 | $19923.00 | -32.2% |
| 2020 | $29402.00 | +18.4% |
| 2019 | $24835.00 | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $30945.00 | +100.3% |
| 2016 | $15449.00 | - |